ABT SEC filings (2026)

About this data#

Abbott Laboratories (ABT) has 3,613 filings on EDGAR going back to 1994: 34 annual reports, 98 quarterly reports and 310 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 20, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Oct 21, 2026, covered other events. Over the last 13 months insiders sold $47.3M in 9 sales and bought $4.4M in 5 purchases; 75 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Abbott Laboratories, read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read ABT's latest 10-K?

ABT's latest annual report, a 10-K, was filed on Feb 20, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did ABT last file an 8-K?

On Oct 21, 2026 it covered other events. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Oct 21, 2026.

Are ABT insiders buying or selling?

Over the last 13 months insiders sold $47.3M in 9 sales and bought $4.4M in 5 purchases; 75 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: MCCOY JOHN A. JR. (VICE PRESIDENT AND CONTROLLER) sold 27 shares on Sep 2, 2026 for $2,958. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has ABT made?

3,613 filings are on EDGAR under the registrant records that have been Abbott Laboratories, going back to 1994; 2,629 of them are insider ownership forms (Forms 3, 4, 5 and 144).